Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Bacterial and Viral Specimen Collection Market Size & Share, By Product (Bacterial Specimen Collection, Viral Specimen Collection), Application (Diagnostics, Research), End-use (Hospitals & Clinics, Home Test, Research Laboratories) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 7315| Published Date: Jan-2025| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Bacterial and Viral Specimen Collection Market size is projected to rise from USD 45.9 billion in 2024 to USD 170.16 billion by 2034, representing a CAGR above 14% for the 2025–2034 forecast period. The industry is estimated to reach USD 51.68 billion in revenue by 2025.

Base Year Value (2024)
USD 45.9 billion
CAGR (2025-2034)
14%
Forecast Year Value (2034)
USD 170.16 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Bacterial and Viral Specimen Collection Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Regional Forecast

Regional Demand Dynamics

Bacterial and Viral Specimen Collection Market
Largest Region
North America
46% Market Share in 2024
North America The North American bacterial and viral specimen collection market is characterized by a strong emphasis on advanced healthcare infrastructure and high adoption rates of innovative diagnostic technologies. In the U.S., federal regulations and guidelines pertaining to specimen collection and handling bolster the market's growth, as healthcare providers focus on improving patient outcomes. The presence of key market players and a robust supply chain network contribute to a competitive landscape. Canada, with its growing healthcare sector, is also witnessing increased investments in infectious disease testing, further propelling the demand for specimen collection products. Asia Pacific In the Asia Pacific region, the bacterial and viral specimen collection market is experiencing rapid growth driven by rising healthcare expenditures and an increasing prevalence of infectious diseases. China leads the market with significant investments in healthcare infrastructure and a rising number of diagnostic laboratories. Japan is focusing on technological advancements in specimen collection methods, enhancing efficiency and accuracy. South Korea's healthcare system is emphasizing preventive care, leading to a higher demand for specimen collection kits. The rising awareness of infectious diseases and government initiatives to improve healthcare access are further supporting market growth across the region. Europe The European market for bacterial and viral specimen collection is influenced by stringent healthcare regulations and a strong focus on quality control measures. The United Kingdom leads the market with advanced healthcare facilities and a high demand for innovative diagnostic solutions. Germany's robust research and development sector and increasing investments in healthcare technologies further enhance market growth. France is witnessing an uptick in the use of molecular diagnostic tests, driving the need for efficient specimen collection methods. Overall, the European market is characterized by a collaborative approach involving public and private sectors to enhance disease surveillance and response capabilities.
Segment Analysis

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Bacterial Specimen Collection The bacterial specimen collection segment is poised for significant growth driven by the increasing prevalence of bacterial infections and the rising demand for accurate diagnostic tools. This segment encompasses various collection methods, including swabs, tubes, and specialized kits designed for isolating and transporting bacterial samples. Technological advancements in collection devices and a growing emphasis on rapid diagnostics are contributing to the expansion of this segment. As healthcare providers prioritize infection control and prevention, the use of bacterial specimen collection products in hospitals, clinics, and research laboratories is expected to rise. Additionally, the integration of these products into routine screening procedures will further augment their market presence. Viral Specimen Collection The viral specimen collection segment has gained prominence, particularly in the wake of global health crises such as the COVID-19 pandemic. The urgency for effective viral diagnostics has elevated the demand for specialized specimen collection tools, including collection swabs, viral transport media, and extraction kits. Health authorities and laboratories seek efficient and reliable methods to collect and transport viral samples, thus ensuring timely and accurate testing. This segment is likely to witness continued growth, propelled by advancements in molecular diagnostics and the increasing focus on infectious disease management. Additionally, the rise in home testing kits for viral infections will contribute positively to the viral specimen collection market, enhancing patient convenience and accessibility. Diagnostics In the diagnostics application segment, specimen collection plays a pivotal role in disease detection and management. The growing emphasis on early diagnosis and point-of-care testing drives the demand for both bacterial and viral specimen collection products. Healthcare providers are investing in advanced diagnostic tools that require efficient and reliable specimen collection methods to ensure accurate results. The rise in chronic diseases and infectious outbreaks necessitates effective specimen collection protocols, facilitating timely treatment decisions. As diagnostic laboratories expand their capabilities and adopt innovative technologies, the diagnostics application segment is expected to experience robust growth, further enhancing the significance of specimen collection in clinical settings. Research The research application segment is essential for advancing scientific knowledge and understanding of various pathogens. Specimen collection tools used in research enable microbiologists, virologists, and epidemiologists to conduct studies and experiments that drive public health policies and intervention strategies. The demand for high-quality specimens to support research on bacterial and viral diseases has led to the development of specialized collection methodologies. Collaboration between research institutions and healthcare providers is fostering innovation in specimen collection techniques, ensuring that researchers have access to reliable samples. As funding for infectious disease research increases and new challenges emerge, the research application segment will continue to be a vital component of the bacterial and viral specimen collection market. Hospitals & Clinics Hospitals and clinics represent a significant end-use segment for the bacterial and viral specimen collection market. These healthcare facilities require efficient and reliable specimen collection methods to ensure accurate diagnostics and effective patient management. With the rising patient population and the increasing incidence of infectious diseases, hospitals and clinics are investing in advanced collection tools to optimize workflow and improve diagnostic accuracy. The need for swift turnaround times in test results is driving demand for efficient specimen collection techniques. Additionally, continuous training and education on best practices for specimen collection are essential for healthcare providers in these settings, thus promoting growth in this end-use segment. Home Test The home test segment is witnessing rapid growth, fueled by the growing trend towards patient-centric healthcare and the demand for convenient self-testing options. Home testing kits for bacterial and viral infections empower individuals to take charge of their health by enabling timely sample collection and diagnosis from the comfort of their homes. The convenience of home testing has been particularly highlighted during the COVID-19 pandemic, which has led to greater acceptance and usage of such products. As technology evolves, the design and usability of home specimen collection kits will continue to improve, attracting more consumers. This trend will further enhance the market for home test solutions, expanding access to vital diagnostic tools. Research Laboratories Research laboratories are a crucial end-use segment for the bacterial and viral specimen collection market, serving as centers for investigating infectious diseases, developing new treatments, and advancing diagnostic methods. These laboratories require high-quality specimen collection tools to facilitate rigorous scientific studies and experiments. The increasing funding for research initiatives, particularly in microbiology and infectious disease fields, is driving the demand for reliable specimen collection solutions. Collaborations between academic institutions and research laboratories also propel innovation in specimen collection techniques and devices. As research initiatives continue to grow in scope and complexity, the demand for sophisticated specimen collection tools in research laboratories will remain strong.
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

The bacterial and viral specimen collection market is characterized by a diverse competitive landscape with several key players vying for market share. Major companies focus on innovation, product development, and strategic partnerships to enhance their offerings and streamline testing processes. The market is driven by the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic tests, and advancements in specimen collection technologies. Companies are also expanding their geographic reach and investing in emerging markets, responding to the growing need for robust and efficient specimen collection solutions across healthcare settings. The competitive dynamics are shaped by collaborations, mergers, and acquisitions aimed at broadening product portfolios and improving customer access to high-quality specimen collection tools. Top Market Players 1. Becton Dickinson and Company 2. Thermo Fisher Scientific Inc. 3. Qiagen N.V. 4. Copan Diagnostics, Inc. 5. Greiner Bio-One International GmbH 6. Merck KGaA 7. Tergene Biotech 8. bioMérieux SA 9. Roche Diagnostics 10. 5P Biotech
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Bacterial and Viral Specimen Collection Market — Custom Segments

Segment Sub-Segment
No segment data available.

Bacterial and Viral Specimen Collection Market — Custom TOC

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →